BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 17892216)

  • 1. In vivo biological responses in the presence or absence of C3.
    Sarma JV; Ward PA
    Adv Exp Med Biol; 2007; 598():240-50. PubMed ID: 17892216
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection of innate immunity by C5aR antagonist in septic mice.
    Huber-Lang MS; Riedeman NC; Sarma JV; Younkin EM; McGuire SR; Laudes IJ; Lu KT; Guo RF; Neff TA; Padgaonkar VA; Lambris JD; Spruce L; Mastellos D; Zetoune FS; Ward PA
    FASEB J; 2002 Oct; 16(12):1567-74. PubMed ID: 12374779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of C5a-induced immunologic derangement in sepsis.
    Xu R; Lin F; Bao C; Wang FS
    Cell Mol Immunol; 2017 Sep; 14(9):792-793. PubMed ID: 28782758
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of C5a in inflammatory responses.
    Guo RF; Ward PA
    Annu Rev Immunol; 2005; 23():821-52. PubMed ID: 15771587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of C5a-C5aR interaction in sepsis.
    Guo RF; Riedemann NC; Ward PA
    Shock; 2004 Jan; 21(1):1-7. PubMed ID: 14676676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement C5a Functions as a Master Switch for the pH Balance in Neutrophils Exerting Fundamental Immunometabolic Effects.
    Denk S; Neher MD; Messerer DAC; Wiegner R; Nilsson B; Rittirsch D; Nilsson-Ekdahl K; Weckbach S; Ignatius A; Kalbitz M; Gebhard F; Weiss ME; Vogt J; Radermacher P; Köhl J; Lambris JD; Huber-Lang MS
    J Immunol; 2017 Jun; 198(12):4846-4854. PubMed ID: 28490576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaphylatoxin C5a-induced toll-like receptor 4 signaling in bovine neutrophils.
    Stevens MG; Van Poucke M; Peelman LJ; Rainard P; De Spiegeleer B; Rogiers C; Van de Walle GR; Duchateau L; Burvenich C
    J Dairy Sci; 2011 Jan; 94(1):152-64. PubMed ID: 21183027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of C5 activation products in sepsis.
    Ward PA
    ScientificWorldJournal; 2010 Dec; 10():2395-402. PubMed ID: 21170490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expressions of C5a and its receptor CD88 after spinal cord injury in C3-deficient mice.
    Guo Q; Cheng J; Zhang H; Zhang J; Su B; Bian C; Lin S
    Scand J Immunol; 2013 Apr; 77(4):224-9. PubMed ID: 23033813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of C3, C5 and anaphylatoxin receptors in acute lung injury and in sepsis.
    Bosmann M; Ward PA
    Adv Exp Med Biol; 2012; 946():147-59. PubMed ID: 21948367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways.
    Ritis K; Doumas M; Mastellos D; Micheli A; Giaglis S; Magotti P; Rafail S; Kartalis G; Sideras P; Lambris JD
    J Immunol; 2006 Oct; 177(7):4794-802. PubMed ID: 16982920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dark side of C5a in sepsis.
    Ward PA
    Nat Rev Immunol; 2004 Feb; 4(2):133-42. PubMed ID: 15040586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis.
    Riedemann NC; Guo RF; Hollmann TJ; Gao H; Neff TA; Reuben JS; Speyer CL; Sarma JV; Wetsel RA; Zetoune FS; Ward PA
    FASEB J; 2004 Feb; 18(2):370-2. PubMed ID: 14688199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement as a Major Inducer of Harmful Events in Infectious Sepsis.
    Fattahi F; Zetoune FS; Ward PA
    Shock; 2020 Nov; 54(5):595-605. PubMed ID: 32187106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief report: complement C5a promotes human embryonic stem cell pluripotency in the absence of FGF2.
    Hawksworth OA; Coulthard LG; Taylor SM; Wolvetang EJ; Woodruff TM
    Stem Cells; 2014 Dec; 32(12):3278-84. PubMed ID: 25132103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD66b Overexpression and Loss of C5a Receptors as Surface Markers for Staphylococcus aureus-Induced Neutrophil Dysfunction.
    Schmidt T; Brodesser A; Schnitzler N; Grüger T; Brandenburg K; Zinserling J; Zündorf J
    PLoS One; 2015; 10(7):e0132703. PubMed ID: 26176669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A key role of C5a/C5aR activation for the development of sepsis.
    Riedemann NC; Guo RF; Ward PA
    J Leukoc Biol; 2003 Dec; 74(6):966-70. PubMed ID: 12960283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil C5a receptor and the outcome in a rat model of sepsis.
    Guo RF; Riedemann NC; Bernacki KD; Sarma VJ; Laudes IJ; Reuben JS; Younkin EM; Neff TA; Paulauskis JD; Zetoune FS; Ward PA
    FASEB J; 2003 Oct; 17(13):1889-91. PubMed ID: 12897064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A second stimulus required for enhanced antifungal activity of human neutrophils in blood is provided by anaphylatoxin C5a.
    Hünniger K; Bieber K; Martin R; Lehnert T; Figge MT; Löffler J; Guo RF; Riedemann NC; Kurzai O
    J Immunol; 2015 Feb; 194(3):1199-210. PubMed ID: 25539819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction.
    Niederbichler AD; Hoesel LM; Westfall MV; Gao H; Ipaktchi KR; Sun L; Zetoune FS; Su GL; Arbabi S; Sarma JV; Wang SC; Hemmila MR; Ward PA
    J Exp Med; 2006 Jan; 203(1):53-61. PubMed ID: 16380509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.